UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[News Focus] Why Korea rushed to raise coronavirus threat level to highest
The Korean government recently lifted the alert level to the highest in the...
by Special Reporting Team
|
2020-02-28 15:01
라인
[New Year Special] Natural stomach drugs get popular after ranitidine ban
In the wake of the ranitidine recall, other antiulcer “tidine-class” drugs,...
by Jeong Sae-im
|
2020-01-07 16:12
라인
[New Year Special] Investors vulnerable to risky biotech business
President Moon Jae-in announced in May that the government would designate ...
by Kim Yun-mi
|
2020-01-02 17:35
라인
Medical info kiosk lends a helping hand for foreign patients
It's not easy navigating a foreign city even if the purpose of the visi...
by Lee Han-soo
|
2020-01-01 05:27
라인
Work hour limit reduces trainee doctors’ time to prepare for specialist exam
The law capping the maximum weekly work hours to 80 for trainee doctors has...
by Kwak Sung-sun
|
2019-12-31 13:33
라인
MSD’s monitoring causes stir for alleged violation of physicians’ privacies
For MSD Korea, 2019 was an embarrassing year.The company’s self-assurance p...
by Kim Yun-mi
|
2019-12-31 12:40
라인
Gore agrees to supply artificial blood vessels for children
W.L. Gore & Associates, the sole provider of artificial vessels used in hea...
by Kwak Sung-sun
|
2019-12-31 10:29
라인
Allergan shrouded in controversy for rare cancer-causing breast implants
Allergan caused a hot controversy this year after worries that its artifici...
by Park Gi-taek
|
2019-12-31 10:20
라인
Korea Biomedical Review’s ‘Top 20’ news
By most accounts, 2019 was another memorable year for Korea’s medical and b...
by Lee Han-soo
|
2019-12-31 10:17
라인
Korea’s biopharmaceutical technology exports top ₩8 trillion won
This was a good year for Korean biopharmaceutical companies in licensing ou...
by Jeong Sae-im
|
2019-12-30 15:26
라인
Industry welcomes legislation of advanced regenerative bio act
The National Assembly finally passed the "Act on Safety and Support for Adv...
by Park Gi-taek
|
2019-12-30 11:56
라인
Court puts brakes on insurers’ reckless suits against hospitals
A Seoul court stopped indemnity insurance companies from indiscriminately f...
by Kim Eun-young
|
2019-12-30 11:35
라인
Anti-abortion law nullified after 66 years
The Constitutional Court ruled that the provisions governing the punishment...
by Kim Eun-young
|
2019-12-30 06:52
라인
Physicians who died at work
The Korean medical community started the year 2019 began with sad news. Yoo...
by Kwak Sung-sun
|
2019-12-29 11:03
라인
Multinational pharmaceuticals' rush to merge face union backlash in Korea
Large multinational pharmaceutical companies have recently announced acquis...
by Kim Yun-mi
|
2019-12-29 10:54
라인
Samsung BioLogics caught red-handed destroying evidence
Samsung BioLogics and Samsung Bioepis were not free from suspicion and cont...
by Jeong Sae-im
|
2019-12-28 12:17
라인
Medical research ethics tarnished by scandal involving former justice minister’s daughter
The appointment of Cho Kuk as the minister of justice was one of the bigges...
by Kwak Sung-sun
|
2019-12-28 12:12
라인
Smaller hospitals suffer from workforce shortage amid rising labor costs
Small and midsize hospitals have usually been in a difficult situation, com...
by Kim Eun-young
|
2019-12-27 15:09
라인
‘No-Japan’ campaign cause anxiety among Japanese pharmaceutical firms
During this year, Japan's export restrictions led to a nationwide boyco...
by Kim Yun-mi
|
2019-12-27 12:08
라인
Did Kolon Life Science intend to deceive both the government and patients?
Kolon Life Science CEO Lee Woo-sok speaks during a news conference on the s...
by Park Gi-taek
|
2019-12-26 14:19
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top